Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001, 345 (9): 656–661
    Baxter, D.: Vaccine responsiveness in premature infants. Hum Vaccin 2010, 6 (6): 506–511
    Bergfors, E., Bjorkelund, C., Trollfors, B.: Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines. Eur J Pediatr 2005, 164 (11): 691–697
    Bernsen, R. M.: Childhood asthma and allergy: the role of vaccinations and other early life events. 20.4.2005. http://repub.eur.nl/res/pub/6749/050420_Bernsen-Roos%20bw23-2B.pdf (Zugriff 9.11.2011)
    Bernsen, R. M., Nagelkerke, N. J., Thijs, C., van der Wouden, J. C.: Reported pertussis infection and risk of atopy in 8- to 12-yr-old vaccinated and nonvaccinated children. Pediatr Allergy Immunol 2008, 19 (1): 46–52
    BGH (Bundesgerichtshof): Urteil v. 15.2.2000 – VI ZR 48/99. http:// www.iww.de/index.cfm?pid=1307&opv=041122 (Zugriff 10. 2. 2012)
    Birn, A. E.: The downside of $ billions. Toronto Star, 16.8.2006. Deutsche Fassung: Die Schattenseite der Dollar-Milliarden. Pharma-Brief 2006, 6: 3f.
    Bishop, N. J., Morley, R., Day, J. P., Lucas, A.: Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 1997, 336 (22): 1557–1561
    Boelen, A., et al.: Both immunisation with a formalin-inactivated respiratory syncytial virus ( RSV ) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV -challenged mice. Vaccine 2000, 19 (7–8): 982–991
    Bohlke, K., Davis, R. L., Marcy, S.M., Braun, M. M., et al.: Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003, 112 (4): 815–820
    Bomford, R.: Aluminium salts: perspectives in their use as adjuvants. In: Gregoriadis GA , Poste AG (Hg): Immunological adjuvants and vaccines. New York, Plenum Press 1989, 35–41
    Borchers, A. T., Keen, C. L., Shoenfeld, Y., Silva, J., Gershwin, M. E.: Vaccines, viruses, and voodoo. J Investig Allergol Clin Immunol 2002, 12 (3): 155–168
    Botham, S.J., et al.: Incidence of apnoea and bradycardia in preterm infants following DTP w and Hib immunization: a prospective study. J Paediatr Child Health, 1997, 33 (5): 418–421
    Bradstreet, J.: Biological evidence of significant vaccine related side-effects resulting in neurodevelopmental disorders. Presentation to the Vaccine Safety Committee of the Institute of Medicine. The National Academics of Science, 9.2.2004. http:// www.nationalautismassociation.org/pdf/ IOM -Bradstreet.pdf (Zugriff 21. 12. 2011)
    Brandis, H., Eggers, H. J., Köhler, W.: Medizinische Mikrobiologie. Gustav-Fischer-Verlag, Stuttgart, 7. überarb. Aufl. 1994
    Braun, M. M., Patriarca, P. A., Ellenberg, S. S.: Syncope after immunization. Arch Pediatr Adolesc Med 1997, 151 (3): 255–259
    Brewer, J. M., Conacher, M., Hunter, C. A., Mohrs, M., Brombacher, F., Alexander, J.: Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL -4- or IL -13-mediated signaling. J Immunol 1999, 163: 6448–6454
    Brunner, R., et al.: Aluminium per se and in the anti-acid drug sucralfate promotes sensitization via the oral route. Allergy 2009, 64: 890–897
    Buchwald, G.: Impfen. Das Geschäft mit der Angst. Knaur 1997
    BUKO Pharma-Brief Nr. 4, Mai/Juni 1999. Rundbrief der BUKO Pharma-Kampagne Health-Action International (D) Editorial. WHO unter Industrieeinfluss – US -Firma sponsert Stelle bei Weltgesundheitsorganisation. http:// www.medicusmundi.ch/mms/services/med/med199905.html (Zugriff 10. 2. 2012)
    Burmistrova, A. L., Gorshunova, L. P., Ebert, L.: Change in the non-specific resistance of the body to influenza and acute respiratory diseases following immunization diphtheria-tetanus vaccine. Zh Mikrobiol Epidemiol Immunobiol 1976; (3): 89ff.
    Burton, D.: FACA : Conflicts of interest and vaccine development: preserving the integrity of the process. Committee on Government Reform, Washington, D. C., 15.6.2000. http:// www.vaccinationnews.com/rally/openstmntconint.htm (Zugriff 10. 2. 2012)
    Burton, A., Waisbren, S.: Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns. Med Hypoth 2008, 70 (2): 346ff.
    Buttery, J., Riddell, A., McVernon, J., Chantler, T., et al.: Immunogenicity and safety of a combination